A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Huvudupphovsman: | Islam, Nahidul |
---|---|
Övriga upphovsmän: | Talukder, Mesbah |
Materialtyp: | Lärdomsprov |
Språk: | English |
Publicerad: |
Brac University
2023
|
Ämnen: | |
Länkar: | http://hdl.handle.net/10361/22025 |
Liknande verk
-
TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
av: Afroza, Halima
Publicerad: (2024) -
Biologics and Biosimilars as Treatment Options for Psoriasis
av: Moya, Amena Khatun
Publicerad: (2023) -
Association of GLP-1 receptor agonists and risk of pancreatitis: a pharmacovigilance study based on FAERS database
av: Bishakha, Adwiza Chakraborty
Publicerad: (2024) -
Safety and efficacy of dutasteride for male Androgenetic Alopecia
av: Islam, S.M. Zahidul
Publicerad: (2024) -
Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
av: Khandker, Tahia Anjum
Publicerad: (2024)